Ajinomoto Co., Inc. (TYO:2802)
3,238.00
+223.00 (7.40%)
May 9, 2025, 3:30 PM JST
Ajinomoto Co. Revenue
In the fiscal year ending March 31, 2025, Ajinomoto Co. had annual revenue of 1.53T JPY with 6.35% growth. Ajinomoto Co. had revenue of 379.52B in the quarter ending March 31, 2025, with 2.14% growth.
Revenue
1,530.56B
Revenue Growth
+6.35%
P/S Ratio
1.97
Revenue / Employee
43.68M
Employees
34,862
Market Cap
2,998.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1,530.56B | 91.33B | 6.35% |
Mar 31, 2024 | 1,439.23B | 80.12B | 5.89% |
Mar 31, 2023 | 1,359.12B | 209.75B | 18.25% |
Mar 31, 2022 | 1,149.37B | 77.92B | 7.27% |
Mar 31, 2021 | 1,071.45B | -28.59B | -2.60% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Japan Tobacco | 3,149.76B |
Seven & i Holdings | 10.34T |
Asahi Group Holdings | 2,939.42B |
Kao Corporation | 1,628.45B |
Pan Pacific International Holdings | 2,176.10B |
Unicharm | 988.98B |
Kirin Holdings Company | 2,338.39B |
Suntory Beverage & Food | 1,696.77B |
Ajinomoto Co. News
- 7 days ago - Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges - Business Wire
- 14 days ago - L-Phenylalanine Market Insights and Forecast to 2030 Featuring Profiles (SWOT, Sales, Prices) of Key Players - Evonik, Ajinomoto, Daesang, and Wuxi Jinghai Amino Acid Co. - GlobeNewsWire
- 14 days ago - L-Alanyl-L-Glutamine Market Report 2025: Includes Insights Into the Sales, Revenue, Price, Gross Margin & SWOT of Kyowa Hakko, Ajinomoto, and Evonik - GlobeNewsWire
- 15 days ago - PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea - Business Wire
- 3 months ago - Q3 2025 Ajinomoto Co Inc Earnings Presentation Transcript - GuruFocus
- 3 months ago - Ajinomoto GAAP EPS of ¥163.08, revenue of ¥1151.04B; reaffirms FY outlook - Seeking Alpha
- 6 months ago - Q2 2025 Ajinomoto Co Inc Earnings Presentation Transcript - GuruFocus
- 6 months ago - Ajinomoto Co., Inc. 2024 Q2 - Results - Earnings Call Presentation - Seeking Alpha